Get the Stockscreener App
1.58
3.27%
0.05
MAIA Biotechnology Inc stock is traded at $1.58, with a volume of 102.18K.
It is up +3.27% in the last 24 hours and down -5.39% over the past month.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
See More
Previous Close:
$1.53
Open:
$1.55
24h Volume:
102.18K
Relative Volume:
0.26
Market Cap:
$52.13M
Revenue:
-
Net Income/Loss:
$-25.94M
P/E Ratio:
-1.1449
EPS:
-1.38
Net Cash Flow:
$-15.79M
1W Performance:
+0.00%
1M Performance:
-5.39%
6M Performance:
-14.59%
1Y Performance:
-47.33%
1-Day Range:
$1.52
$1.585
1-Week Range:
$1.50
$1.62
52-Week Range:
$1.40
$3.742
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Name
MAIA Biotechnology Inc
Sector
Industry
Phone
312 416 8592
Address
444 West Lake Street, Suite 1700, Chicago
Compare MAIA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.58 | 52.13M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
MAIA Biotechnology Inc Stock (MAIA) Latest News
Watch for Bullish Crossover in MAIA Biotechnology Inc.2025 Earnings Surprises & Fast Exit/Entry Strategy Plans - beatles.ru
Using flow based indicators on MAIA Biotechnology Inc.Treasury Yields & AI Enhanced Market Trend Forecasts - Newser
What moving averages say about MAIA Biotechnology Inc.Stop Loss & Accurate Entry/Exit Alerts - Newser
Is MAIA Biotechnology Inc. stock reversal real or fakeInsider Selling & Technical Entry and Exit Tips - Newser
What recovery options are there for MAIA Biotechnology Inc.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Volatility clustering patterns for MAIA Biotechnology Inc.July 2025 Sentiment & Verified Momentum Watchlists - Newser
Has MAIA Biotechnology Inc. formed a bullish divergenceQuarterly Trade Summary & Verified Entry Point Signals - Newser
Price Clustering Detected in MAIA Biotechnology Inc. StockJuly 2025 Price Swings & AI Optimized Trade Strategies - 선데이타임즈
What’s next for MAIA Biotechnology Inc. stock priceJuly 2025 Technicals & Real-Time Volume Analysis Alerts - Newser
MAIA Biotechnology Q2 2025: Strong Phase 2 NSCLC Survival Data, Fast Track Designation. - AInvest
Relative strength of MAIA Biotechnology Inc. in sector analysisJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Is MAIA Biotechnology Inc. still worth holding after the dip2025 Key Lessons & Free Accurate Trade Setup Notifications - Newser
Why MAIA Biotechnology Inc. stock attracts strong analyst attentionEarnings Overview Summary & AI Driven Stock Movement Reports - Newser
Is MAIA Biotechnology Inc. showing signs of accumulationWeekly Trade Report & Safe Capital Growth Trade Ideas - Newser
Comparing MAIA Biotechnology Inc. in custom built stock radarsPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Key resistance and support levels for MAIA Biotechnology Inc.Market Risk Summary & Reliable Intraday Trade Alerts - Newser
Applying Wyckoff theory to MAIA Biotechnology Inc. stockWeekly Profit Analysis & Expert Curated Trade Setup Alerts - Newser
Fibonacci Support Holding Strong in MAIA Biotechnology Inc.Market Risk Summary & Fast Entry Momentum Alerts - sundaytimes.kr
MAIA Biotechnology Inc. stock trend forecastJuly 2025 Institutional & Fast Entry and Exit Trade Plans - Newser
How to escape a deep drawdown in MAIA Biotechnology Inc.Gap Up & High Accuracy Investment Signals - Newser
Does MAIA Biotechnology Inc. fit your quant trading model2025 Institutional Moves & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-08-16 21:11:22 - Newser
When is the best time to exit MAIA Biotechnology Inc.Portfolio Risk Summary & High Yield Equity Trading Tips - Newser
Custom watchlist performance reports with MAIA Biotechnology Inc.July 2025 Pullbacks & Stepwise Trade Signal Implementation - Newser
Candlestick signals on MAIA Biotechnology Inc. stock todayJuly 2025 Catalysts & Low Risk Growth Stock Ideas - Newser
MAIA Biotechnology Secures European Patent for Cancer Therapy - MSN
Maia Biotechnology shares fall 1.19% intraday after European Patent granted for telomere-targeting anticancer therapy. - AInvest
Moving Average Trends for MAIA Biotechnology Inc. Stock: What They IndicateWeekly Risk Summary & Precise Swing Trade Alerts - Newser
Strategies to average down on MAIA Biotechnology Inc.2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
MAIA Biotechnology, Inc. Grants European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy - MarketScreener
MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy - GlobeNewswire
MAIA's New Cancer Drug Patent Combines Telomere Targeting with Immunotherapy for Better Results - Stock Titan
What is MAIA Biotechnology Inc.’s market positionTrade Picks with 3x Upside - kangso.co.kr
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
MAIA Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Regression analysis insights on MAIA Biotechnology Inc. performancePredictive Short-Term Market Reversal Alerts - Newser
What machine learning models say about MAIA Biotechnology Inc.Free ROI Driven Equity Selection With Safety - Newser
Technical analysis overview for MAIA Biotechnology Inc. stockCapital Growth Summary Over Five Years - Newser
Published on: 2025-08-04 17:15:59 - metal.it
How volatile is MAIA Biotechnology Inc. stock compared to the marketBuild wealth with proven stock investing tactics - Jammu Links News
What analysts say about MAIA Biotechnology Inc. stockMaster stock selection with insider knowledge - Jammu Links News
Why is MAIA Biotechnology Inc. stock attracting strong analyst attentionGet timely alerts on top market movers - Jammu Links News
What institutional investors are buying MAIA Biotechnology Inc. stockAchieve consistent profits with smart trading - Jammu Links News
Should I hold or sell MAIA Biotechnology Inc. stock in 2025Maximize gains with strategic stock entries - Jammu Links News
What makes MAIA Biotechnology Inc. stock price move sharplyIdentify winners with top-tier analysis - Jammu Links News
MAIA Biotechnology Inc. Stock Analysis and ForecastMaximize your portfolio’s growth potential - Jammu Links News
MAIA Biotechnology Inc Stock (MAIA) Financials Data
Revenue
Net Income
Cash Flow
EPS
MAIA Biotechnology Inc Stock (MAIA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Guerrero Ramiro | Director |
May 08 '25 |
Buy |
1.50 |
20,000 |
30,000 |
588,218 |
| Smith Stan | Director |
May 08 '25 |
Buy |
1.50 |
66,666 |
99,999 |
1,271,726 |
| Guerrero Ramiro | Director |
Mar 03 '25 |
Buy |
1.50 |
33,333 |
50,000 |
568,218 |
| Smith Stan | Director |
Mar 03 '25 |
Buy |
1.50 |
25,000 |
37,500 |
1,205,060 |
| Guerrero Ramiro | Director |
Feb 24 '25 |
Buy |
1.50 |
73,333 |
110,000 |
534,885 |
| Smith Stan | Director |
Feb 24 '25 |
Buy |
1.50 |
50,000 |
75,000 |
1,180,060 |
| Smith Stan | Director |
Dec 13 '24 |
Buy |
1.87 |
25,000 |
46,800 |
1,130,060 |
| Guerrero Ramiro | Director |
Dec 13 '24 |
Buy |
1.87 |
53,418 |
99,998 |
514,970 |
| Luput Cristian | Director |
Nov 01 '24 |
Buy |
2.51 |
22,133 |
55,554 |
389,483 |
| CHAOUKI STEVEN M | Director |
Nov 01 '24 |
Buy |
2.51 |
22,133 |
55,554 |
111,024 |
0.94%
1.72%
Cap:
|
Volume (24h):